EUCTR2019-004208-37-BE进行中(未招募)1 期
Drug repurposing - Statins as microbiota modulating agents in ulcerative colitis - ReMiDy
Z Leuven0 个研究点目标入组 400 人开始时间: 2020年3月4日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •General criteria
- •Bact2 enterotyped one month before start of study intervention (at least 150 of enrolled participants must meet this criteria)
- •Willingness to participate in the study and to sign the informed consent (Dutch)
- •Between 18 and 75 years old
- •Access to a -20°C freezer
- •Criteria specific to UC patients
- •Patients in remission (mayo score below 4) or with currently mild to moderate active ulcerative colitis (defined by Mayo score of 4-10), despite stable medication (8 weeks) and a Mayo endoscopic sub-score 2-3 at week 0
- •Criteria specific to healthy Bact2 participants
- •Individuals with no physician diagnosed diseases or disorders
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 300
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 100
排除标准
- •General criteria
- •Prior and/or ongoing use of statins before study start
- •History of surgical intervention in gastrointestinal tract
- •Females who are pregnant or actively trying to become pregnant
- •Individuals with active liver disease including unexplained persistent elevations of serum transaminases and any serum transaminases elevation exceeding three times the upper limit of normal (ULN)
- •Lactose intolerance
- •Pre-diabetic participants
- •Personal or family history of hereditary muscular disorders
- •Individuals with a history of or diagnosed with alcohol abuse
- •Criteria specific to UC patients
- •Other conditions leading to profound immunosuppression such as HIV, infectious diseases leading to immunosuppression, bone marrow malignancies, liver cirrhosis
- •A diagnosis of Crohn’s disease or indeterminate colitis
- •Individuals with hypothyroidism
- •Individuals with a diagnosis of diabetes mellitus
- •Individuals with severe renal impairment (creatinine clearance <30 ml/min)
- •Individuals with myopathy
- •Participants who have taken antibiotics sometime in the past four months
- •Use of antibiotics one month prior to week 0
- •Steroid dependency and requiring >16mg Medrol (methyl prednisone) or equivalent two week before week 0
- •Criteria specific to healthy Bact2 participants
- •Participants with family history of autoimmune chronic inflammatory diseases like multiple sclerosis, IBD, and rheumatoid arthritis
研究者
相似试验
已完成
不适用
Statins for Digital Ulcers and Raynaud's Phenomenon in systemic sclerosisSystemic sclerosisISRCTN26319635niversity of Alexandria (Egypt)80
终止
3 期
atural products to lower cholesterolstatin intoleranceCardiovascular - Other cardiovascular diseaseshyperlipidemiacardiovascular diseaseACTRN12618000660280Curtin University49
Unknown
4 期
Probiotic BIO-25 as a Supplement to Statins for the Treatment of HypercholesterolemiaHypercholesterolemiaNCT01849185Meir Medical Center60
进行中(未招募)
1 期
Statins for treatment of liver cirrhosis. The STATLiver TrialEUCTR2019-001806-40-DKAfsnit 360, Gastroenheden182
尚未招募
不适用
To study the effect of lipid lowering drugs in the eye manifestations of diabetic patientsCTRI/2020/07/026588ADVANCED EYE CENTER
